Synchon halted its clinical trial after the latest brain‑computer implant failed to meet performance targets. The pause follows internal testing that showed the device lagged in signal fidelity and power consumption.[…

The startup announced it will redesign the implant’s hardware and begin work on a new generation device. No timeline was given, but the company emphasized that patient safety remains the priority. The decision undersc…

Industry observers note that the setback may slow broader adoption of neural interfaces in clinical settings. Regulatory bodies have yet to issue new guidance, leaving companies to rely on existing medical device path…

AI‑Powered Outbound Calling Gets a Price Tag